- Home
- AGNCM vs SNN Comparison
AGNCM vs SNN Comparison
Compare AGNCM & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNCM | SNN |
|---|---|---|
| Founded | 2008 | 1856 |
| Country | United States | United Kingdom |
| Employees | 54 | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 12.3B |
| IPO Year | 2008 | 2002 |
Fundamental Metrics
Financial Performance| Metric | AGNCM | SNN |
|---|---|---|
| Price | $25.37 | $26.82 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 14.6K | ★ 1.7M |
| Earning Date | 01-26-2026 | 03-16-2026 |
| Dividend Yield | ★ 8.99% | 2.48% |
| EPS Growth | ★ 58.06 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.57 | $8.58 |
| Revenue Next Year | $63.17 | $5.60 |
| P/E Ratio | $68.05 | ★ $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.63 | $26.70 |
| 52 Week High | $25.54 | $37.51 |
Technical Indicators
Market Signals| Indicator | AGNCM | SNN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 32.36 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $31.36 |
| Average True Range (ATR) | 0.00 | 0.45 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.